Clinical Trial Update: Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating dupilumab in patients with atopic keratoconjunctivitis (AKC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Keratoconjunctivitis

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Andover Eye Associates | Conditions: Atopic Keratoconjunctivitis | Phase 2 | Status: UNKNOWN